The report assesses Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) targeted therapeutics based on mechanism of action (MoA ...

Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with Bio-Thera for BAT2506, a Proposed Golimumab Biosimilar PR Newswire Mon, Feb 10, 2025, 8:30 AM 4 min read ...

(RTTNews) - Alvotech (ALVO), a biotech company, and Teva Pharmaceutical Industries Limited (TEVA), a pharmaceutical company, on Monday, announced that the FDA has accepted for review the Biologics ...